Want to see AU:BMT full AI Analyst Report?
Top Page
Beamtree Holdings Ltd
(Sydney:BMT)
Select Model
Select Model
Rating:50Neutral
Price Target:
AU$0.13
▼(-40.91% Downside)
Action:Reiterated
Date:07/01/26
The score is held down primarily by weak financial performance (loss-making operations, negative revenue growth, and cash flow strain). Technicals provide a partial offset with improving short-term momentum, but valuation remains constrained by negative earnings and the absence of a dividend yield.
Positive Factors
High gross margin
A 100% gross margin signals software-centric economics where direct costs are minimal. Over the medium term this provides structural leverage: as revenue recovers, incremental sales can flow to the operating line, enabling sustainable margin expansion if operating expenses are managed.
Negative Factors
Negative profitability
Persistent negative EBIT/EBITDA and net margins weaken retained earnings and limit the firm’s ability to self-fund growth. Over months this compresses strategic optionality, forces cost restructuring or dilutive capital raises, and makes delivering consistent returns to shareholders harder.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross margin
A 100% gross margin signals software-centric economics where direct costs are minimal. Over the medium term this provides structural leverage: as revenue recovers, incremental sales can flow to the operating line, enabling sustainable margin expansion if operating expenses are managed.
Read all positive factors
Beamtree Holdings Ltd (BMT) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$37.79M
Dividend YieldN/A
Average Volume (3M)122.51K
Price to Earnings (P/E)―
Beta (1Y)0.97
Revenue Growth0.03%
EPS Growth-5.85%
CountryAU
Employees97
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.02
Shares Outstanding290,696,170
10 Day Avg. Volume152,204
30 Day Avg. Volume122,509
Financial Highlights & Ratios
PEG Ratio-0.66
Price to Book (P/B)1.72
Price to Sales (P/S)2.53
P/FCF Ratio-39.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$34.83M
Beamtree Holdings Ltd Business Overview & Revenue Model
Company Description
Headquartered in Redfern, Australia, Beamtree Holdings Limited, founded in 1996, develops and markets cutting-edge clinical decision support (CDS) solutions for the healthcare sector, both within Australia and globally. The company offers a divers...
How the Company Makes Money
null...
Beamtree Holdings Ltd Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.90M | 28.60M | 27.60M | 22.77M | 16.55M | 8.39M |
| Gross Profit | 1.66M | 28.60M | 4.89M | 2.14M | -202.00K | 2.77M |
| EBITDA | -780.00K | -808.00K | -331.00K | -1.26M | -2.28M | 1.02M |
| Net Income | -5.78M | -6.16M | -5.11M | -6.91M | -4.45M | -383.62K |
Balance Sheet | ||||||
| Total Assets | 53.26M | 54.29M | 59.65M | 62.53M | 63.91M | 47.05M |
| Cash, Cash Equivalents and Short-Term Investments | 2.94M | 4.78M | 5.04M | 8.81M | 6.35M | 14.12M |
| Total Debt | 3.65M | 3.26M | 1.66M | 755.00K | 1.12M | 799.36K |
| Total Liabilities | 13.76M | 12.36M | 12.52M | 15.31M | 15.33M | 4.96M |
| Stockholders Equity | 39.51M | 41.93M | 47.14M | 47.22M | 48.58M | 42.09M |
Cash Flow | ||||||
| Free Cash Flow | 906.00K | -1.84M | -4.51M | -1.88M | -4.83M | -2.64M |
| Operating Cash Flow | 1.08M | 609.00K | -492.00K | 768.00K | -2.32M | 240.65K |
| Investing Cash Flow | -3.37M | -2.45M | -4.02M | -2.65M | -5.16M | -2.98M |
| Financing Cash Flow | 1.54M | 1.58M | 749.00K | 4.34M | -286.00K | 12.65M |
Beamtree Holdings Ltd Technical Analysis
Negative
0.22
Price Trends
0.12
Positive
0.13
Negative
0.17
Negative
Market Momentum
<0.01
Positive
48.38
Neutral
28.57
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:BMT, the sentiment is Negative. The current price of 0.22 is above the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.12, and above the 200-day MA of 0.17, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 48.38 is Neutral, neither overbought nor oversold. The STOCH value of 28.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:BMT.
Beamtree Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | AU$20.59B | 88.44 | 72.67% | 0.24% | 30.33% | 138.71% | |
67 Neutral | AU$131.67M | 33.79 | 4.37% | ― | 36.43% | ― | |
55 Neutral | AU$72.85M | -7.28 | -23.86% | ― | -11.45% | -97.22% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | AU$37.79M | -6.00 | -14.19% | ― | 0.03% | -5.85% | |
48 Neutral | AU$130.43M | -6.19 | -226.75% | ― | 29.37% | -10.38% | |
44 Neutral | AU$24.04M | -3.13 | -1009.84% | ― | 13.69% | 7.57% |
* Healthcare Sector Average
AU:BMT
Beamtree Holdings Ltd
0.13
-0.14
-51.85%
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
0.17
-0.08
-34.00%
AU:PME
Pro Medicus Limited
198.98
-124.54
-38.49%
AU:M7T
Mach7 Technologies
0.33
-0.04
-12.16%
AU:ALC
Alcidion Group Limited
0.10
>-0.01
-3.00%
AU:PCK
PainChek Ltd
0.11
-0.31
-73.81%
Beamtree Holdings Ltd Corporate Events
Beamtree Discloses Board Change as Director James Birch Steps Down
Jun 30, 2026
Beamtree Holdings Limited has announced that James Birch has ceased to be a director of the company as of 30 June 2026, according to a Final Director’s Interest Notice lodged with the ASX. The filing confirms Birch holds no securities as a r...
Beamtree Director Bradley Lancken Steps Down but Retains Indirect Stake
Jun 30, 2026
Beamtree Holdings Limited has announced the cessation of Bradley Lancken as a director of the company, effective 30 June 2026. The final director’s interest notice lodged with the ASX confirms that while Lancken holds no shares directly, he ...
Beamtree Director Mike Hill Increases Indirect Shareholding via Super Fund
Jun 24, 2026
Beamtree Holdings Limited has reported a change in director Mike Hill’s indirect shareholding, reflecting an increase in his exposure to the company through his superannuation vehicle. The shares are held via Jarumitoti Superannuation Fund P...
Beamtree Issues 2 Million Unquoted Performance Rights Under Incentive Scheme
May 12, 2026
Beamtree Holdings Limited has issued 2,000,000 unquoted performance rights under its employee incentive scheme, with the new securities recorded under ASX code BMTAC and an issue date of 12 May 2026. The move signals the company’s ongoing us...
Beamtree Performance Rights Lapse After Vesting Conditions Not Met
May 11, 2026
Beamtree Holdings Ltd has announced the lapse of 1,000,000 performance rights under its issued capital, as the conditions attached to these rights were not met or became incapable of being satisfied by 24 April 2026. The cessation of these securit...
Beamtree Issues 770,000 Unquoted Performance Rights Under Employee Incentive Scheme
May 11, 2026
Beamtree Holdings Ltd has issued 770,000 unquoted performance rights under its employee incentive scheme, with an issue date of May 1, 2026. These performance rights, which will not be quoted on the ASX, indicate the company’s continued use ...
Beamtree Wins A$2m Saudi Contract and Tightens Strategy Amid Cost Reset
May 5, 2026
Beamtree Holdings has secured a A$2 million, 12‑month contract with Saudi Arabia’s Fakeeh Care Group to provide coding, coding assurance and analytics services as the hospital operator adapts to major clinical coding and reimbursement ...
Beamtree Seeks ASX Quotation for New Employee Incentive Shares
Apr 28, 2026
Beamtree Holdings has applied for quotation on the ASX of 52,954 new ordinary fully paid shares issued to employees under its Employee Incentive Plan. The shares were allotted on 28 April 2026 as part of salary contribution arrangements, reinforci...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.